Liver Transplantation

Papers
(The median citation count of Liver Transplantation is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-02-01 to 2024-02-01.)
ArticleCitations
Coronaviruses and Immunosuppressed Patients: The Facts During the Third Epidemic497
Analysis of Liver Resection Versus Liver Transplantation on Outcome of Small Intrahepatic Cholangiocarcinoma and Combined Hepatocellular‐Cholangiocarcinoma in the Setting of Cirrhosis61
The Role of Ischemia/Reperfusion Injury in Early Hepatic Allograft Dysfunction55
Racial, Gender, and Socioeconomic Disparities in Liver Transplantation52
Antibody Response to Severe Acute Respiratory Syndrome‐Coronavirus‐2 Messenger RNA Vaccines in Liver Transplant Recipients50
Sequential Use of Normothermic Regional and Ex Situ Machine Perfusion in Donation After Circulatory Death Liver Transplant49
Physical Function, Physical Activity, and Quality of Life After Liver Transplantation48
Longterm Outcomes of Patients Undergoing Liver Transplantation for Acute‐on‐Chronic Liver Failure45
Liver Transplantation for Acute‐on‐Chronic Liver Failure: Science or Fiction?44
A Review of the Current State of Liver Transplantation Disparities41
Chronic Kidney Disease in Liver Transplant Candidates: A Rising Burden Impacting Post–Liver Transplant Outcomes39
Hypothermic Oxygenated Perfusion Improves Extended Criteria Donor Liver Graft Function and Reduces Duration of Hospitalization Without Extra Cost: The PERPHO Study38
Machine Perfusions in Liver Transplantation: The Evidence‐Based Position Paper of the Italian Society of Organ and Tissue Transplantation34
Assessment and Transplantation of Orphan Donor Livers: A Back‐to‐Base Approach to Normothermic Machine Perfusion34
Cirrhotic Cardiomyopathy Predicts Posttransplant Cardiovascular Disease: Revelations of the New Diagnostic Criteria34
Introducing EL‐FIT (Exercise and Liver FITness): A Smartphone App to Prehabilitate and Monitor Liver Transplant Candidates32
Safety and Benefit of Transesophageal Echocardiography in Liver Transplant Surgery: A Position Paper From the Society for the Advancement of Transplant Anesthesia (SATA)32
Changes in Liver Transplant Center Practice in Response to Coronavirus Disease 2019: Unmasking Dramatic Center‐Level Variability31
Sarcopenia in Children With End‐Stage Liver Disease on the Transplant Waiting List31
Using Artificial Intelligence for Predicting Survival of Individual Grafts in Liver Transplantation: A Systematic Review31
Immunogenicity and Adverse Effects of the 2‐Dose BNT162b2 Messenger RNA Vaccine Among Liver Transplantation Recipients31
Liver Transplantation for Acute Intermittent Porphyria30
The Stanford Integrated Psychosocial Assessment for Transplant Is Associated With Outcomes Before and After Liver Transplantation30
Liver Transplantation From Controlled Donors After Circulatory Death Using Normothermic Regional Perfusion: An Initial French Experience30
Bile Composition as a Diagnostic and Prognostic Tool in Liver Transplantation29
A 6‐Month Report on the Impact of the Organ Procurement and Transplantation Network/United Network for Organ Sharing Acuity Circles Policy Change28
The Effect of Acuity Circles on Deceased Donor Transplant and Offer Rates Across Model for End‐Stage Liver Disease Scores and Exception Statuses28
Low Health Literacy Is Associated With Frailty and Reduced Likelihood of Liver Transplant Listing: A Prospective Cohort Study28
The Emerging Role of Viability Testing During Liver Machine Perfusion26
The New Horizon of Split‐Liver Transplantation: Ex Situ Liver Splitting During Hypothermic Oxygenated Machine Perfusion25
Higher Mortality in Pediatric Liver Transplant Candidates With Sarcopenia25
Living Donor Liver Transplantation in the United States: Evolution of Frequency, Outcomes, Center Volumes, and Factors Associated With Outcomes25
The Role of Ex Situ Hypothermic Oxygenated Machine Perfusion and Cold Preservation Time in Extended Criteria Donation After Circulatory Death and Donation After Brain Death24
Preliminary Analysis of the Impact of the Coronavirus Disease 2019 Outbreak on Italian Liver Transplant Programs24
Pure Laparoscopic Donor Hepatectomy: A Multicenter Experience23
The Microbiome and Hepatocellular Carcinoma23
Clinical Factors Associated With Lack of Serological Response to SARS‐CoV‐2 Messenger RNA Vaccine in Liver Transplantation Recipients23
Cirrhosis Is Associated With High Mortality and Readmissions Over 90 Days Regardless of COVID‐19: A Multicenter Cohort23
Longterm Survival After Liver Transplantation for Autoimmune Hepatitis: Results From the European Liver Transplant Registry23
Graft Programmed Death Ligand 1 Expression as a Marker for Transplant Rejection Following Anti–Programmed Death 1 Immunotherapy for Recurrent Liver Tumors23
Frailty Is Associated With Increased Rates of Acute Cellular Rejection Within 3 Months After Liver Transplantation22
The Current Management of Hepatorenal Syndrome–Acute Kidney Injury in the United States and the Potential of Terlipressin22
In‐Person Outreach and Telemedicine in Liver and Intestinal Transplant: A Survey of National Practices, Impact of Coronavirus Disease 2019, and Areas of Opportunity22
Role of Molecular Biomarkers in Liver Transplantation for Hepatocellular Carcinoma21
Donor‐Transmitted Cancers in Transplanted Livers: Analysis of Clinical Outcomes21
Similar Results in Liver Transplantation From Controlled Donation After Circulatory Death Donors With Normothermic Regional Perfusion and Donation After Brain Death Donors: A Case‐Matched Single‐Cente21
Estimating Glomerular Filtration Rate in Cirrhosis Using Creatinine‐Based and Cystatin C–Based Equations: Systematic Review and Meta‐Analysis21
Post–Liver Transplant Acute Kidney Injury20
Use of Artificial Intelligence as an Innovative Method for Liver Graft Macrosteatosis Assessment20
Differential Impact of Extended Criteria Donors After Brain Death or Circulatory Death in Adult Liver Transplantation20
Impact of the Severe Acute Respiratory Syndrome Coronavirus 2 Outbreak on Pediatric Liver Transplant Recipients in Lombardy, Northern Italy20
A 3‐Decade, Single‐Center Experience of Liver Transplantation for Cholangiocarcinoma: Impact of Era, Tumor Size, Location, and Neoadjuvant Therapy20
The Impact of the 2017 Kidney Allocation Policy Change on Simultaneous Liver‐Kidney Utilization and Outcomes19
Multicenter study of racial and ethnic inequities in liver transplantation evaluation: Understanding mechanisms and identifying solutions19
The Predictive Role of Model for End‐Stage Liver Disease–Lactate and Lactate Clearance for In‐Hospital Mortality Among a National Cirrhosis Cohort19
Sirolimus or Everolimus Improves Survival After Liver Transplantation for Hepatocellular Carcinoma: A Systematic Review and Meta‐Analysis19
In situ normothermic regional perfusion versus ex situ normothermic machine perfusion in liver transplantation from donation after circulatory death19
Time to Conversion to an Everolimus‐Based Regimen: Renal Outcomes in Liver Transplant Recipients From the EVEROLIVER Registry19
Outcomes of Liver Transplantation Among Older Recipients With Nonalcoholic Steatohepatitis in a Large Multicenter US Cohort: the Re‐Evaluating Age Limits in Transplantation Consortium19
Patient Frailty Is Independently Associated With the Risk of Hospitalization for Acute‐on‐Chronic Liver Failure18
Liver Transplantation in Children With Propionic Acidemia: Medium‐Term Outcomes18
Steroid‐Resistant Acute Cellular Rejection of the Liver After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA Vaccination18
Cirrhotic cardiomyopathy: Appraisal of the original and revised criteria in predicting posttransplant cardiac outcomes18
The Role of Salvage Transplantation in Patients Initially Treated With Open Versus Minimally Invasive Liver Surgery: An Intention‐to‐Treat Analysis18
Liver Transplant Survivorship17
Improvement in Quality of Life and Decrease in Large‐Volume Paracentesis Requirements With the Automated Low‐Flow Ascites Pump17
Psychosocial Assessment Rather Than Severity of Liver Failure Dominates Selection for Liver Transplantation in Patients With Alcohol‐Related Liver Disease17
Outcomes of Coronavirus Disease 2019 in Living Donor Liver Transplant Recipients17
Liver Transplantation Using Hepatitis C Virus–Viremic Donors Into Hepatitis C Virus–Aviremic Recipients as Standard of Care17
Liver transplantation of partial grafts after ex situ splitting during hypothermic oxygenated perfusion—The HOPE–Split pilot study17
A review of racial, socioeconomic, and geographic disparities in pediatric liver transplantation17
Guillain‐Barré Syndrome After COVID‐19 mRNA Vaccination in a Liver Transplantation Recipient With Favorable Treatment Response17
Improved National Results With Simultaneous Liver‐Kidney Transplantation Using Donation After Circulatory Death Donors17
Feasibility and Effectiveness of Norepinephrine Outside the Intensive Care Setting for Treatment of Hepatorenal Syndrome16
Variation in Racial Disparities in Liver Transplant Outcomes Across Transplant Centers in the United States16
Use of Skeletal Muscle Index as a Predictor of Wait‐List Mortality in Patients With End‐Stage Liver Disease16
Use of Hepatitis C Nucleic Acid Test–Positive Liver Allografts in Hepatitis C Virus Seronegative Recipients16
Outcomes of Acute Liver Injury in Adults Due to Wilson’s Disease: Is Survival Without Transplant Possible?16
Extensive Health Care Utilization and Costs of an Early Liver Transplantation Program for Alcoholic Hepatitis16
Regulatory T Cell Therapy Following Liver Transplantation16
Location and allocation: Inequity of access to liver transplantation for patients with severe acute‐on‐chronic liver failure in Europe16
Donation After Circulatory Death Is Associated With Similar Posttransplant Survival in All but the Highest‐Risk Hepatocellular Carcinoma Patients16
Pregnancy in Liver Transplantation16
Extracellular Vesicles as a Novel Therapeutic Option in Liver Transplantation16
Pulmonary Vascular Resistance Predicts Mortality and Graft Failure in Transplantation Patients With Portopulmonary Hypertension15
Financial burden in adults with chronic liver disease: A scoping review15
Pure Laparoscopic Versus Open Left Hepatectomy Including the Middle Hepatic Vein for Living Donor Liver Transplantation15
Serum MicroRNA Signatures in Recovery From Acute and Chronic Liver Injury and Selection for Liver Transplantation15
Regorafenib Efficacy After Sorafenib in Patients With Recurrent Hepatocellular Carcinoma After Liver Transplantation: A Retrospective Study15
Long‐term Outcomes of Pediatric Living Versus Deceased Donor Liver Transplantation Recipients: A Systematic Review and Meta‐analysis15
Macitentan Improves Risk Categorization for Liver Transplant Mortality in Patients With Portopulmonary Hypertension: A PORTICO Study Post Hoc Analysis15
A New Approach for Increasing Availability of Liver Grafts and Donor Safety in Living Donor Liver Transplantation: LD‐RAPID Procedure in the Cirrhotic Setting With Hepatocellular Carcinoma15
Post‐transplant Lymphoproliferative Disorders After Liver Transplantation: A Retrospective Cohort Study Including 1954 Transplants15
Donor Morbidity Is Equivalent Between Right and Left Hepatectomy for Living Liver Donation: A Meta‐Analysis15
Association of Perfusion Characteristics and Posttransplant Liver Function in Ischemia‐Free Liver Transplantation15
Medicaid Expansion Association With End‐Stage Liver Disease Mortality Depends on Leniency of Medicaid Hepatitis C Virus Coverage14
Eight‐Fold Increase in Dietary Supplement–Related Liver Failure Leading to Transplant Waitlisting Over the Last Quarter Century in the United States14
External Validation of the VOCAL‐Penn Cirrhosis Surgical Risk Score in 2 Large, Independent Health Systems14
Risk Factors for Posttransplantation Mortality in Recipients With Grade 3 Acute‐on‐Chronic Liver Failure: Analysis of a North American Consortium14
Intraoperative Continuous Renal Replacement Therapy During Liver Transplantation: A Meta‐Analysis14
Liver Transplantation in Children with Urea Cycle Disorders: The Importance of Minimizing Waiting Time14
Propensity Score–Matched Analysis of Posttransplant Outcomes in Living Donor Liver Transplantation for Older Adult Recipients14
Coronary Computed Tomography Angiography Demonstrates a High Burden of Coronary Artery Disease Despite Low‐Risk Nuclear Studies in Pre–Liver Transplant Evaluation14
Identifying Modifiable Predictors of Long‐Term Survival in Liver Transplant Recipients With Diabetes Mellitus Using Machine Learning14
Seroconversion After Coronavirus Disease 2019 Vaccination in Patients Awaiting Liver Transplantation: Fact or Fancy?14
Incorporating Tumor Biology to Predict Hepatocellular Carcinoma Recurrence in Patients Undergoing Living Donor Liver Transplantation Using Expanded Selection Criteria14
Family Planning in Liver Transplant: Patient and Provider Knowledge and Practices13
Minimally Invasive Living Donor Liver Transplantation: Pure Laparoscopic Explant Hepatectomy and Graft Implantation Using Upper Midline Incision13
Introduction of the Concept of Diagnostic Sensitivity and Specificity of Normothermic Perfusion Protocols to Assess High‐Risk Donor Livers13
Allograft Fibrosis After Pediatric Liver Transplantation: Incidence, Risk Factors, and Evolution13
National Trends in Location of Death in Patients With End‐Stage Liver Disease13
Viability assessment and transplantation of fatty liver grafts using end‐ischemic normothermic machine perfusion13
Early Everolimus‐Facilitated Reduced Tacrolimus in Liver Transplantation: Results From the Randomized HEPHAISTOS Trial13
Bile Biochemistry Following Liver Reperfusion in the Recipient and Its Association With Cholangiopathy13
Technical Choices in Pediatric Living Donor Liver Transplantation: The Path to Reduce Vascular Complications and Improve Survival13
Neighborhood poverty is associated with failure to be waitlisted and death during liver transplantation evaluation13
Deceased Donor Liver Transplantation After Radioembolization for Hepatocellular Carcinoma and Portal Vein Tumoral Thrombosis: A Pilot Study13
Pretransplant Intensive Care Unit Management and Selection of Grade 3 Acute‐on‐Chronic Liver Failure Transplant Candidates13
Assessment of Deceased Brain Dead Donor Liver Grafts via Normothermic Machine Perfusion: Lactate Clearance Time Threshold Can Be Safely Extended to 6 Hours13
Paradigm Change in Liver Transplantation Practice After the Implementation of the Liver‐Kidney Allocation Policy12
Impact of Preexisting Inflammatory Bowel Disease on the Outcome of Liver Transplantation for Primary Sclerosing Cholangitis12
Cardiac Risk Stratification in Liver Transplantation: Results of a Tiered Assessment Protocol Based on Traditional Cardiovascular Risk Factors12
Renal Outcomes After Simultaneous Liver‐Kidney Transplantation: Results from the US Multicenter Simultaneous Liver‐Kidney Transplantation Consortium12
Deceased Donor Liver Transplantation from a SARS‐CoV‐2–Positive Donor to a SARS‐CoV‐2–Positive Recipient12
Genomics and Liver Transplantation: Genomic Biomarkers for the Diagnosis of Acute Cellular Rejection12
Ursodeoxycholic Acid Decreases Incidence of Primary Biliary Cholangitis and Biliary Complications After Liver Transplantation: A Meta‐Analysis12
Inpatient Frailty Assessment Is Feasible and Predicts Nonhome Discharge and Mortality in Decompensated Cirrhosis12
Successful Pregnancy in a Liver Transplant Recipient on Belatacept12
Outcomes of patients with acute liver failure listed for liver transplantation: A multicenter prospective cohort analysis12
Clinical Outcomes of Portosystemic Shunts on the Outcome of Liver Transplantation12
Monitoring of Donor‐Derived Cell‐Free DNA by Short Tandem Repeats: Concentration of Total Cell‐Free DNA and Fragment Size for Acute Rejection Risk Assessment in Liver Transplantation12
Laparoscopic Living Donor Right Hepatectomy Regarding the Anatomical Variation of the Portal Vein: A Propensity Score–Matched Analysis12
Acute Liver Failure Etiology Is an Independent Predictor of Waitlist Outcome but Not Posttransplantation Survival in a National Cohort12
Addition of [18F]Fluorodeoxyglucose Positron Emission Tomography With Computed Tomography to Cross‐Sectional Imaging Improves Staging and Alters Management in Hepatocellular Carcinoma12
Cerium oxide nanoparticles administration during machine perfusion of discarded human livers: A pilot study11
Monoacylglycerol Acyltransferase 1 Knockdown Exacerbates Hepatic Ischemia/Reperfusion Injury in Mice With Hepatic Steatosis11
Kidney Graft Outcomes in High Immunological Risk Simultaneous Liver‐Kidney Transplants11
The Current Landscape of Liver Transplantation After Ex Situ Machine Perfusion and Normothermic Regional Perfusion in the United States11
Outcomes of Liver Transplant for Adults With Wilson’s Disease11
Survival Benefit of Split‐Liver Transplantation for Pediatric and Adult Candidates11
Recurrence After Curative Resection of Hepatitis B Virus–Related Hepatocellular Carcinoma: Diagnostic Algorithms on Gadoxetic Acid–Enhanced Magnetic Resonance Imaging11
The Future of Quality Improvement for Cirrhosis11
What Survivorship Means to Liver Transplant Recipients: Qualitative Groundwork for a Survivorship Conceptual Model11
Elevated fractional donor‐derived cell‐free DNA during subclinical graft injury after liver transplantation11
What Liver Transplant Recipients Want in a Smartphone Intervention to Enhance Recovery: Prototype for the LiveRight Transplant App11
Coronaviruses and Immunosuppressed Patients: The Facts During the Third Epidemic11
Clinical Significance of Spontaneous Portosystemic Shunts in Living Donor Liver Transplantation11
Outcomes in Living Donor Compared With Deceased Donor Primary Liver Transplantation in Lower Acuity Patients With Model for End‐Stage Liver Disease Scores <3011
Hypothermic oxygenated machine perfusion as a tool to facilitate liver transplantation in the acute‐on‐chronic liver failure scenario11
Development of Ectopic Livers by Hepatocyte Transplantation Into Swine Lymph Nodes11
Role of Novel Kidney Biomarkers in Patients With Cirrhosis and After Liver Transplantation11
Impact of major hepatocellular carcinoma policy changes on liver transplantation for hepatocellular carcinoma in the United States11
Unfair Advantages for Hepatocellular Carcinoma Patients Listed for Liver Transplant in Short‐Wait Regions Following 2015 Hepatocellular Carcinoma Policy Change10
Interleukin‐10 and Transforming Growth Factor‐β Cytokines Decrease Immune Activation During Normothermic Ex Vivo Machine Perfusion of the Rat Liver10
Resection of Mixed Hepatocellular‐Cholangiocarcinoma, Hepatocellular Carcinoma, and Intrahepatic Cholangiocarcinoma10
Use of Dual Hypothermic Oxygenated Machine Perfusion to Recover Extended Criteria Pediatric Liver Grafts10
Risk Factors and Center‐Level Variation in Hepatocellular Carcinoma Under‐Staging for Liver Transplantation10
Can Living Donor Liver Transplantation in the United States Reach Its Potential?10
Utility of Preoperative Computed Tomography–Based Body Metrics in Relation to Postoperative Complications in Pediatric Liver Transplantation Recipients10
Liver Transplantation for Acute Liver Injury in Asians Is More Likely Due to Herbal and Dietary Supplements10
Cannabinoid Use Among Liver Transplant Recipients10
Early Predictors of Short‐Term Prognosis in Acute and Acute Severe Autoimmune Hepatitis10
Renal Dysfunction After Liver Transplantation: Effect of Donor Type10
Histidine‐Rich Glycoprotein Alleviates Liver Ischemia/Reperfusion Injury in Mice With Nonalcoholic Steatohepatitis10
Is Blood Transfusion a Means of False Positive Phosphatidylethanol Testing?10
Gut Microbial Signature of Hepatocellular Cancer in Men With Cirrhosis10
Changes in Liver Transplant Center Practice in Response to Coronavirus Disease 2019: Unmasking Dramatic Center‐Level Variability10
Redefining Success After Liver Transplantation: From Mortality Toward Function and Fulfillment10
Superior Long‐Term Outcomes of Adult Living Donor Liver Transplantation: A Cumulative Single‐Center Cohort Study With 20 Years of Follow‐Up10
Extending the Use of Atezolizumab and Bevacizumab to a Liver Transplant Recipient: Need for a Posttransplant Registry10
Long‐Term Safety and Efficacy of Pure Laparoscopic Donor Hepatectomy in Pediatric Living Donor Liver Transplantation10
Metabolic Complications in Liver Transplantation Recipients: How We Can Optimize Long‐Term Survival10
Efficacy and Safety of Endoscopic Balloon Placement for Weight Loss in Patients With Cirrhosis Awaiting Liver Transplantation10
Donor eligibility criteria and liver graft acceptance criteria during normothermic regional perfusion: A systematic review10
Coronavirus Disease 2019 and Liver Transplantation: Lessons from the First Year of the Pandemic9
Drug‐Induced Liver Injury After Liver Transplantation9
Hepatitis E Virus Infection in the United States: Current Understanding of the Prevalence and Significance in the Liver Transplant Patient Population and Proposed Diagnostic and Treatment Strategies9
Recent Improvement in Survival Outcomes and Reappraisal of Prognostic Factors in Pediatric Living Donor Liver Transplantation9
Liver Transplant Recipient, Caregiver, and Provider Perceptions of Cardiovascular Disease and Related Risk Factors After Transplant9
Intraoperative risk factors of acute kidney injury after liver transplantation9
Definition and Prospective Assessment of Functional Recovery After Liver Transplantation: A New Objective Consensus‐Based Metric for Safe Discharge9
Indocyanine Green Fluorescence Imaging to Predict Graft Survival After Orthotopic Liver Transplantation: A Pilot Study9
Caregiver perspectives on the everyday medical and social needs of long‐term pediatric liver transplant patients9
Platelets Stimulate Liver Regeneration in a Rat Model of Partial Liver Transplantation9
Phenotypic, Transcriptional, and Functional Analysis of Liver Mesenchymal Stromal Cells and Their Immunomodulatory Properties9
Comparison of Wait‐List Mortality Between Cholangiocarcinoma and Hepatocellular Carcinoma Liver Transplant Candidates9
Development and Validation of a Model to Predict Long‐Term Survival After Liver Transplantation9
Donation after circulatory death transplant outcomes using livers recovered by local surgeons9
Physiologic Reserve Assessment and Application in Clinical and Research Settings in Liver Transplantation9
Planned Initiation of Venoarterial Extracorporeal Membrane Oxygenation Prior to Liver Transplantation in a Patient With Severe Portopulmonary Hypertension9
Early Survivorship After Liver Transplantation: A Qualitative Study Identifying Challenges in Recovery From the Patient and Caregiver Perspective9
Complete transition from open surgery to laparoscopy: 8‐year experience with more than 500 laparoscopic living donor hepatectomies9
Anticancer Effect of Statins in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma9
Excellent Outcome in Living Donor Liver Transplantation: Treating Patients With Acute‐on‐Chronic Liver Failure9
MicroRNAs 155‐5p, 122‐5p, and 181a‐5p Identify Patients With Graft Dysfunction Due to T Cell–Mediated Rejection After Liver Transplantation9
Combined Lung and Liver Transplantation for Short Telomere Syndrome9
Center Variation in Intention‐to‐Treat Survival Among Patients Listed for Liver Transplant9
Opioid Avoidance in Liver Transplant Recipients: Reduction in Postoperative Opioid Use Through a Multidisciplinary Multimodal Approach9
The Impact of Median Model for End‐Stage Liver Disease at Transplant Minus 3 National Policy on Waitlist Outcomes in Patients With and Without Hepatocellular Carcinoma9
A Multicentric Experience on Living Donor Liver Transplantation in Coronavirus Disease 2019 Hotspots in India8
Tool to Aid Patients in Selecting a Liver Transplant Center8
Longterm Outcome of Liver Transplantation for Congenital Extrahepatic Portosystemic Shunt8
New‐Onset Antibodies to Platelet Factor 4 Following Liver Transplantation From a Donor With Vaccine‐Induced Thrombotic Thrombocytopenia8
Variation in Bile Microbiome by the Etiology of Cholestatic Liver Disease8
Living Donor Liver Transplantation When Deceased Donor Is Not Possible or Timely: Case Examples and Ethical Perspectives8
Demarcating the Exact Midplane of the Liver Using Indocyanine Green Near‐Infrared Fluorescence Imaging During Laparoscopic Donor Hepatectomy8
Association of serum metabolites and gut microbiota at hospital admission with nosocomial infection development in patients with cirrhosis8
Deficits in Muscle Strength and Physical Performance Influence Physical Activity in Sarcopenic Children After Liver Transplantation8
Preliminary Evaluation of Atezolizumab Plus Bevacizumab as Salvage Treatment for Recurrent Hepatocellular Carcinoma After Liver Transplantation8
Identifying Patients at Highest Risk of Remaining Unvaccinated Against Severe Acute Respiratory Syndrome Coronavirus 2 in a Large Veterans Health Administration Cohort8
Improvements in Disease‐Specific Health‐Related Quality of Life of Pediatric Liver Transplant Recipients During Immunosuppression Withdrawal8
Black Race Is Associated With Higher Rates of Early‐Onset End‐Stage Renal Disease and Increased Mortality Following Liver Transplantation8
Coronavirus Disease 2019 in the Early Postoperative Period of Liver Transplantation: Is the Outcome Really So Positive?8
Low‐dose aspirin confers protection against acute cellular allograft rejection after primary liver transplantation8
Portal vein complications and outcomes following pediatric liver transplantation: Data from the Society of Pediatric Liver Transplantation8
Portal Vein Complications After Adult Living Donor Liver Transplantation: Time of Onset and Deformity Patterns Affect Long‐Term Outcomes8
Cardiac Risk Assessment in Liver Transplant Candidates: A Survey of National Practice Patterns8
Center use of technical variant grafts varies widely and impacts pediatric liver transplant waitlist and recipient outcomes in the United States8
The 6‐Minute Walk Test Distance Predicts Mortality in Cirrhosis: A Cohort of 694 Patients Awaiting Liver Transplantation8
Managing Recipient Hepatic Artery Intimal Dissection During Living Donor Liver Transplantation8
Multicenter, Double‐Blind, Randomized Trial of Emricasan in Hepatitis C–Treated Liver Transplant Recipients With Residual Fibrosis or Cirrhosis8
Cadence From Physical Activity Trackers for Monitoring of Home‐Based Exercise Intensity in Advanced Liver Disease8
Microsteatosis in Livers From Donation After Circulatory Death Donors Is Associated With Inferior Outcomes Following Liver Transplantation7
Clinical Value of Surveillance Biopsies in Pediatric Liver Transplantation7
Nonalcoholic Fatty Liver Disease and Diabetes Mellitus Are Associated With Post–Transjugular Intrahepatic Portosystemic Shunt Renal Dysfunction: An Advancing Liver Therapeutic Approaches Group Study7
Malnutrition in Biliary Atresia: Assessment, Management, and Outcomes7
Temporal Trends and Evolving Outcomes After Simultaneous Liver‐Kidney Transplantation: Results from the US SLKT Consortium7
Activated CD4+ T Cells and Highly Differentiated Alloreactive CD4+ T Cells Distinguish Operationally Tolerant Liver Transplantation Recipients7
Debate on Selection Criteria for Liver Transplantation for Alcoholic Hepatitis: Tighten or Loosen?7
Molecular Mismatch Predicts T Cell–Mediated Rejection and De Novo Donor‐Specific Antibody Formation After Living Donor Liver Transplantation7
Frailty Is a Risk Factor for Postoperative Mortality in Patients With Cirrhosis Undergoing Diverse Major Surgeries7
Black patients and women have reduced access to liver transplantation for alcohol‐associated liver disease7
Direct‐Acting Antivirals and Hepatocellular Carcinoma: No Evidence of Higher Wait‐List Progression or Posttransplant Recurrence7
Development of a portable abdominal normothermic regional perfusion (A-NRP) program in the United States7
Secondary Prophylaxis of Gastric Variceal Bleeding: A Systematic Review and Network Meta‐Analysis7
Association of Donor and Recipient Cytomegalovirus Serostatus on Graft and Patient Survival in Liver Transplant Recipients7
Hepatic Encephalopathy and Liver Transplantation: The Past, Present, and Future Toward Equitable Access7
Role of Terlipressin and Albumin for Hepatorenal Syndrome in Liver Transplantation6
Impact of Medial Reduction of the Left Lateral Segment: A Novel Technique for Living Donor Liver Transplantation for Small Pediatric Recipients6
Cost‐Effectiveness of Primary Liver Transplantation Versus Hepatoportoenterostomy in the Management of Biliary Atresia in the United States6
Two‐Stage Recipient Hepatectomy and Left Liver Transplantation to Minimize Risks in Adult‐to‐Adult Living Donor Liver Transplantation: New Concepts6
Mending the Model for End‐Stage Liver Disease: An in‐depth review of the past, present, and future portopulmonary hypertension Model for End‐Stage Liver Disease exception6
Low Immunoglobulin G Antibody Levels Against Severe Acute Respiratory Disease Coronavirus 2 After 2‐Dose Vaccination Among Liver Transplantation Recipients6
Livers From Pediatric Donation After Circulatory Death Donors Represent a Viable and Underutilized Source of Allograft6
Impact of the Kasai Procedure and the Length of Native Liver Survival Time on Outcomes of Liver Transplantation for Biliary Atresia6
Occult Hepatocellular Carcinoma Associated With Transjugular Intrahepatic Portosystemic Shunts in Liver Transplant Recipients6
Challenging the Traditional Paradigm of Supply and Demand in Pediatric Liver Transplantation Through Nondirected Living Donation: A Case Series6
International Population Study in Spain, Cuba, and the United States of Attitudes Toward Organ Donation Among the Cuban Population6
The Impact of Primary Liver Disease and Social Determinants in a Mixed Donor Liver Transplant Program: A Single‐Center Analysis6
Circulating Tumor Cell–Based Messenger RNA Scoring System for Prognostication of Hepatocellular Carcinoma: Translating Tissue‐Based Messenger RNA Profiling Into a Noninvasive Setting6
0.072961807250977